COMMUNIQUÉS West-GlobeNewswire

NSS Labs Announces Industry’s First Breach Prevention System Group Test Results

13/12/2017 - 15:00

AUSTIN, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent fact-based cybersecurity guidance, today announced the results of its Breach Prevention Systems (BPS) [...]

Stemline Therapeutics Presents Detailed SL-401 Pivotal Data in BPDCN at ASH and Kicks Off its BPDCN Awareness Campaign; Updated Results From Ongoing Trials in Additional Malignancies Also Presented

13/12/2017 - 14:36

NEW YORK, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, presented detailed data [...]

Cascadian Therapeutics Added to the Nasdaq Biotechnology Index

13/12/2017 - 14:35

SEATTLE, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (Nasdaq: CASC ), a clinical-stage biopharmaceutical company, today announced that it has been selected for addition to the Nasdaq Biotechnology [...]

Nuvectra Achieves 1,000th Algovita® SCS System Implantation in U.S.

13/12/2017 - 14:01

PLANO, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that the company’s Algovita ® Spinal Cord Stimulation (SCS) system has now [...]

Amalgam Rx Partners with UCB on BEYOND™, a Digital Health Solution for Patients with Psoriasis and Psoriatic Arthritis

13/12/2017 - 14:00

WILMINGTON, Del., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Allay Rx, a subsidiary of Amalgam Rx, Inc. , a leading digital therapeutics company, announced today a partnership on a comprehensive behavioral and patient support [...]

Women In Bio Holds First Annual Boardroom Ready Reception & Retreat for 2016/2017 Alumni in New York

13/12/2017 - 14:00

Application Process for the 2018 Boardroom Ready Program begins late December BOSTON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Women In Bio (WIB) an organization of professionals committed to promoting careers, leadership, and [...]

eTrueNorth Expands its eLabNetwork™ Platform Internationally

13/12/2017 - 14:00

DALLAS, Dec. 13, 2017 (GLOBE NEWSWIRE) -- e TrueNorth, the U.S.-based healthcare technology solution provider for CLIA-waived laboratories, announced today that it has grown its business internationally with a new [...]

Xbrane Biopharma informs about changes in management team

13/12/2017 - 13:31

Pressrelease 2017-12-13 Xbrane Biopharma AB ("Xbrane" or "the Company") announces that Carlo Colombo, Head of Production within Xbranes long acting injectable business, who forms a part of Xbranes management team, has [...]

Nephros Receives $1.8 Million in Cash from Sale of Tax Credits

13/12/2017 - 13:30

SOUTH ORANGE, NJ, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]

Marinus Pharmaceuticals Added to NASDAQ Biotechnology Index

13/12/2017 - 13:30

RADNOR, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]

Strongbridge Biopharma plc Added to the NASDAQ Biotech Index

13/12/2017 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

Iovance Biotherapeutics Announces Manufacturing Decision, Provides Clinical Updates and Highlights Pipeline Expansion at Analyst Day 2017

13/12/2017 - 13:05

- Generation 2 Manufacturing Process Selected for All Ongoing and Future TIL Clinical Development - - Company Reports Updated Results for Cohort 2 in Melanoma Study - - Two New Studies in NSCLC Patients in Collaboration [...]

Iovance Biotherapeutics Expands Pipeline of TIL Therapies into Lung Cancer

13/12/2017 - 13:00

Moffitt Cancer Center Phase 1 Study Combining TIL and Nivolumab Initiated in NSCLC Patients Iovance/MedImmune Clinical Collaboration to Initiate with Start of Phase 2 Study in PD-1/PDL-1 Naïve NSCLC Patients 1H 2018 SAN [...]

GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.

13/12/2017 - 13:00

LONDON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

National Research Corporation Announces Revised Class B Common Stock Recapitalization Plan

13/12/2017 - 13:00

All class B shares to be exchanged for one share of class A common stock plus $19.59 in cash, for total value of $53.44 per class B share Class A common stock to be sole outstanding security of the Company Previously [...]

Q Therapeutics Announces Research Collaboration With REPROCELL

13/12/2017 - 13:00

SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury, announced a collaborative [...]

Natus to Present at J.P. Morgan 36th Annual Healthcare Conference

13/12/2017 - 13:00

PLEASANTON, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice [...]

argenx announces size of proposed public offering in the United States updated to 3.5 million ADSs

13/12/2017 - 12:00

Regulated information - Inside information December 13, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of [...]

Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo

13/12/2017 - 10:56

Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that the company will present at the DNB Nordic Healthcare Conference on 14th of December 2017 in Oslo, Norway. Presenter will be Ambaw Bellete [...]